PETMED EXPRESS INCPETSEarnings & Financial Report
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
PETS Q3 FY2026 Key Financial Metrics
Revenue
$40.7M
Gross Profit
$9.5M
Operating Profit
$-10.5M
Net Profit
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
-26.0%
YoY Growth
-23.3%
EPS
$-0.50
PETMED EXPRESS INC Q3 FY2026 Financial Summary
PETMED EXPRESS INC reported revenue of $40.7M (down 23.3% YoY) for Q3 FY2026, with a net profit of $-10.6M (down 1392.6% YoY) (-26.0% margin). Cost of goods sold was $31.2M, operating expenses totaled $19.9M.
Key Financial Metrics
| Total Revenue | $40.7M |
|---|---|
| Net Profit | $-10.6M |
| Gross Margin | 23.3% |
| Operating Margin | -25.7% |
| Report Period | Q3 FY2026 |
Revenue Breakdown
PETMED EXPRESS INC Q3 FY2026 revenue of $40.7M breaks down across 3 segments, led by Reorder at $34.0M (83.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Reorder | $34.0M | 83.7% |
| New Order | $5.0M | 12.4% |
| Membership Fees | $1.6M | 4.0% |
PETMED EXPRESS INC Revenue by Segment — Quarterly Trend
PETMED EXPRESS INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Reorder and New Order) has evolved quarter over quarter.
| Segment | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Reorder | $34.0M | $37.4M | $41.3M | — |
| New Order | $5.0M | $5.3M | $8.2M | — |
| Membership Fees | $1.6M | $1.6M | $1.6M | — |
PETMED EXPRESS INC Annual Revenue by Year
PETMED EXPRESS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $227.0M).
PETMED EXPRESS INC Quarterly Revenue & Net Profit History
PETMED EXPRESS INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2026 | $40.7M | -23.3% | $-10.6M | -26.0% |
| Q2 FY2026 | $44.4M | -25.5% | $-8.5M | -19.2% |
| Q1 FY2026 | $51.2M | -24.7% | $-34.2M | -66.7% |
| Q4 FY2025 | $50.8M | -22.0% | $-11.6M | -22.9% |
| Q3 FY2025 | $52.0M | -18.4% | $-707.0K | -1.4% |
| Q2 FY2025 | $58.0M | -16.4% | $2.3M | 4.0% |
| Q1 FY2025 | $66.2M | -12.8% | $3.8M | 5.7% |
| Q4 FY2024 | $65.1M | +8.8% | $-5.0M | -7.7% |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.1M | $66.2M | $58.0M | $52.0M | $50.8M | $51.2M | $44.4M | $40.7M |
| YoY Growth | 8.8% | -12.8% | -16.4% | -18.4% | -22.0% | -24.7% | -25.5% | -23.3% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $169.9M | $152.7M | $146.0M | $144.8M | $148.7M | $109.8M | $100.3M | $88.0M |
| Liabilities | $73.2M | $59.2M | $49.6M | $48.6M | $63.6M | $58.3M | $57.2M | $55.2M |
| Equity | $96.7M | $93.5M | $96.4M | $96.2M | $85.1M | $51.5M | $43.1M | $32.8M |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $7.1M | $-8.5M | $7.4M | $-1.2M | $7.0M | $-12.3M | $-2.2M | $-9.2M |